<table id="_refid288" width="494.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_046b81b1-5404-4200-9c96-e2d8143f0e22">Table 13 Established and Other Potentially Significant Drug Interactions</caption>
<col width="37.4%"></col>
<col width="24.3%"></col>
<col width="38.3%"></col>
<thead>
<tr id="id_da5cdb0d-d716-46c5-9e8c-2de6324c1cfd">
<td align="left" stylecode="Botrule Toprule Rrule Lrule" valign="top">
<content stylecode="bold">Concomitant Drug</content>
<br/>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Effect on Concentration of Lamotrigine or Concomitant Drug</content>
<br/>
</td>
<td align="left" stylecode="Botrule Toprule Rrule Lrule" valign="top">
<content stylecode="bold">Clinical Comment</content>
<br/>
</td>
</tr>
</thead>
<tfoot id="id_557cd2ad-3cc4-458a-a33a-da357e71c1d7">
<tr>
<td align="left" colspan="3" stylecode="Lrule Botrule Rrule" valign="top">↓ = Decreased (induces lamotrigine glucuronidation)<br/>
</td>
</tr>
<tr>
<td align="left" colspan="3" stylecode="Lrule Botrule Rrule" valign="top">↑ = Increased (inhibits lamotrigine glucuronidation)<br/>
</td>
</tr>
<tr>
<td align="left" colspan="3" stylecode="Lrule Botrule Rrule" valign="top">? = Conflicting data<br/>
</td>
</tr>
</tfoot>
<tbody>
<tr id="id_b363405f-da8d-437c-a5c7-954ff1608e1c">
<td align="left" stylecode="Lrule Toprule Rrule" valign="top">
<paragraph>Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↓ lamotrigine<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Decreased lamotrigine levels approximately 50%<br/>
</paragraph>
</td>
</tr>
<tr id="id_e0ac66d4-13fc-46fa-9bb3-fda703131ada">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↓ levonorgestrel<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Decrease in levonorgestrel component by 19%<br/>
</paragraph>
</td>
</tr>
<tr id="id_dce06be7-648c-401d-b9f2-b03800539919">
<td align="left" stylecode="Lrule Rrule" valign="top">
<paragraph>Carbamazepine (CBZ) and CBZ epoxide<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↓ lamotrigine<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%<br/>
</paragraph>
</td>
</tr>
<tr id="id_28d19472-3f57-41eb-81f7-2408ba7590e6">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>? CBZ epoxide<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>May increase CBZ epoxide levels.<br/>
</paragraph>
</td>
</tr>
<tr id="id_fd77ea7a-2f4d-4047-9bbb-3d2905393242">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>Phenobarbital/Primidone<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↓ lamotrigine<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Decreased lamotrigine concentration approximately 40%<br/>
</paragraph>
</td>
</tr>
<tr id="id_0cb33344-e3f3-49d3-b2cc-d98fcbfcc455">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>Phenytoin (PHT)<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↓ lamotrigine<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Decreased lamotrigine concentration approximately 40%<br/>
</paragraph>
</td>
</tr>
<tr id="id_cd53308f-ff96-40d9-b4bb-e625a9972fe2">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>Rifampin<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↓ lamotrigine<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Decreased lamotrigine AUC approximately 40%<br/>
</paragraph>
</td>
</tr>
<tr id="id_1a8c608b-a7ef-48a6-8391-4c13a8452092">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">
<paragraph>Valproate<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↑ lamotrigine<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Increased lamotrigine concentrations slightly more than 2-fold<br/>
</paragraph>
</td>
</tr>
<tr id="id_c8b02fa8-aae8-40c0-aa2c-f060d1bb3e19">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>? valproate<br/>
</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients.<br/>
</paragraph>
</td>
</tr>
</tbody>
</table>